New Investment From The Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator (Dxa) Leads Efforts To Develop ...
(MENAFN- PR Newswire) The DxA partners with Dr's Henrik Zetterberg and Nicholas Ashton to create critical standardized reference materials for leading Alzheimer's blood biomarker, p-Tau217, to ensure consistency across global research and clinical …